The head of one of the world's largest pharmaceutical companies has ruled out donations of vaccines to protect the poor against the latest flu pandemic, saying that developing countries or donor nations should cover the costs.
Daniel Vasella, chief executive of Novartis, based in Switzerland, told the FT he would consider offering discounted pricing on flu vaccines to low-income nations, but said: “If you want to make production sustainable, you have to create financial incentives.”
His comments were a rebuff to Margaret Chan, director-general of the World Health Organisation, which has declared that the H1N1 swine flu outbreak is now a pandemic. She has called on vaccine makers to show “solidarity” in offering vaccines to the poor.